Answers are grounded in this paper and cite their sources.
Hepatitis B is a significant infectious disease on a global scale. The implementation of vaccination programs and other preventive measures (e.g., serologic screening of blood donors) leads to lower rates of new infections with the hepatitis B virus. This study aimed to investigate and compare the evolution of hepatitis B incidence, prevalence and mortality rates along with vaccination rates in Türkiye and worldwide between 1990 and 2019.
No takes yet. Share an insight, caveat, or question.
Okan Derin (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: